LAB icon

Standard BioTools
LAB

Overview Fund Activity

66 hedge funds and large institutions have $89.1M invested in Standard BioTools in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 15 closing their positions.

Holders
66
Holders Change
-3
Holders Change %
-4.35%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
11
Reduced
25
Closed
15
Calls
$29K
Puts
$62K
Net Calls
-$33K
Net Calls Change
+$200K

Top Buyers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$4.06M
2
CC
2
Casdin Capital
New York
$2.32M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.21M
4
SAM
4
Silverback Asset Management
North Carolina
$869K
5
MCP
5
Mirador Capital Partners
California
$92.6K

Top Sellers

1
Primecap Management
1
Primecap Management
California
$6.22M
2
NIM
2
Needham Investment Management
New York
$3.93M
3
Millennium Management
3
Millennium Management
New York
$1.13M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$663K
5
Jane Street
5
Jane Street
New York
$74.3K
Name Holding Trade Value Shares
Change 		Shares
Change %
CWM
76
CarsonAllaria Wealth Management
Illinois
– -$7.83K -4,015 Closed
BA
77
Bellwether Advisors
Nebraska
– -$3.93K -2,016 Closed
BAM
78
Belpointe Asset Management
Nevada
– -$3.9K -2,000 Closed
ASN
79
Advisory Services Network
Georgia
– -$975 -500 Closed
NA
80
NewEdge Advisors
Louisiana
– -$330 -169 Closed
1 2 3
4